Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 3—March 2005

Research

Ebola Virus Antibody Prevalence in Dogs and Human Risk

Loïs Allela*, Olivier Bourry*, Régis Pouillot†, André Délicat*, Philippe Yaba*, Brice Kumulungui*, Pierre Rouquet*, Jean-Paul Gonzalez‡, and Eric M. Leroy*‡Comments to Author 
Author affiliations: *Centre International de Recherches Médicales de Franceville, Franceville, Gabon; †Centre Pasteur du Cameroun, Yaoundé, Cameroun; ‡Institut de Recherche pour le Développement, Paris, France

Main Article

Figure 2

Seroprevalence of Ebola virus in dogs sampled in different areas: A) France, major towns of Gabon, Mekambo (a town close to the disease-epidemic area) and villages in the epidemic area; B) France, major towns of Gabon, Mekambo, villages without human cases and villages with human cases; C) France, major towns of Gabon, Mekambo, villages with and without an animal source. Estimates are represented by squares, bounded by their 95% Clopper and Pearson confidence intervals. The dashed line is the li

Figure 2. . . Seroprevalence of Ebola virus in dogs sampled in different areas: A) France, major towns of Gabon, Mekambo (a town close to the disease-epidemic area) and villages in the epidemic area; B) France, major towns of Gabon, Mekambo, villages without human cases and villages with human cases; C) France, major towns of Gabon, Mekambo, villages with and without an animal source. Estimates are represented by squares, bounded by their 95% Clopper and Pearson confidence intervals. The dashed line is the linear trend in proportion.

Main Article

¹Loïs Allela and Olivier Bourry contributed equally to this work.

TOP